John Couling Sells 7,667 Shares of Dolby Laboratories (NYSE:DLB) Stock

03 Sep 2026, 21:12 by Doug Wharley · The Cerbat Gem

Dolby Laboratories (NYSE:DLB – Get Free Report) SVP John Couling sold 7,667 shares of Dolby Laboratories stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $61.05, for a total transaction of $468,070.35. Following the sale, the senior vice president owned 118,727 shares of the company’s stock, valued at $7,248,283.35. The trade was a 6.07% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Dolby Laboratories Stock Performance

NYSE DLB traded up $0.16 on Thursday, reaching $61.95. 777,418 shares of the stock traded hands, compared to its average volume of 924,476. Dolby Laboratories has a 12 month low of $48.26 and a 12 month high of $73.78. The company has a fifty day moving average price of $56.41 and a 200-day moving average price of $58.30. The company has a market cap of $5.80 billion, a price-to-earnings ratio of 26.36 and a beta of 0.80.

Dolby Laboratories (NYSE:DLB – Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The electronics maker reported $0.69 EPS for the quarter, beating the consensus estimate of $0.67 by $0.02. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. The business had revenue of $305.00 million during the quarter, compared to analyst estimates of $311.96 million. During the same quarter in the previous year, the business posted $0.78 EPS. The company’s quarterly revenue was down 3.3% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. As a group, research analysts anticipate that Dolby Laboratories will post 3.23 earnings per share for the current fiscal year.

Dolby Laboratories Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, August 19th. Investors of record on Tuesday, August 11th were given a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend was Tuesday, August 11th. Dolby Laboratories’s dividend payout ratio is currently 61.28%.

Dolby Laboratories announced that its Board of Directors has authorized a share buyback program on Thursday, July 30th that allows the company to buyback $350.00 million in outstanding shares. This buyback authorization allows the electronics maker to reacquire up to 7% of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s board believes its shares are undervalued.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on DLB. Wall Street Zen lowered shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Rosenblatt Securities restated a “buy” rating and issued a $85.00 price objective on shares of Dolby Laboratories in a research report on Friday, August 28th. Weiss Ratings cut Dolby Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, August 13th. Finally, Barrington Research reiterated an “outperform” rating and issued a $90.00 target price on shares of Dolby Laboratories in a research report on Monday, June 15th. Two equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Dolby Laboratories presently has a consensus rating of “Hold” and a consensus target price of $83.00.

Get Our Latest Analysis on Dolby Laboratories

Institutional Investors Weigh In On Dolby Laboratories

A number of institutional investors and hedge funds have recently made changes to their positions in DLB. Fifth Third Bancorp raised its position in Dolby Laboratories by 34.7% in the fourth quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock valued at $48,000 after purchasing an additional 192 shares during the period. Aquatic Capital Management LLC purchased a new stake in shares of Dolby Laboratories in the 3rd quarter valued at $56,000. iSAM Funds UK Ltd purchased a new position in Dolby Laboratories during the 3rd quarter valued at about $68,000. Quarry LP increased its stake in Dolby Laboratories by 1,486.7% during the fourth quarter. Quarry LP now owns 1,190 shares of the electronics maker’s stock worth $76,000 after purchasing an additional 1,115 shares during the period. Finally, Farther Finance Advisors LLC boosted its stake in shares of Dolby Laboratories by 48.4% in the fourth quarter. Farther Finance Advisors LLC now owns 1,232 shares of the electronics maker’s stock valued at $79,000 after purchasing an additional 402 shares during the period. 58.56% of the stock is owned by hedge funds and other institutional investors.

About Dolby Laboratories

(Get Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.